Nuveen Asset Management, LLC Beam Therapeutics Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 181,636 shares of BEAM stock, worth $4.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,636
Previous 184,596 1.6%
Holding current value
$4.78 Million
Previous $4.52 Million 0.4%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$21.55 - $30.35 $63,788 - $89,836
-2,960 Reduced 1.6%
181,636 $4.5 Million
Q2 2024

Aug 09, 2024
BUY
$21.22 - $32.66 $220,794 - $339,827
10,405 Added 5.97%
184,596 $4.33 Million
Q1 2024

May 13, 2024
SELL
$23.46 - $45.07 $80,796 - $155,221
-3,444 Reduced 1.94%
174,191 $5.76 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $54,042 - $93,971
-3,055 Reduced 1.69%
177,635 $4.84 Million
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $221,034 - $311,810
9,606 Added 5.61%
180,690 $4.35 Million
Q2 2023

Aug 14, 2023
SELL
$29.32 - $35.99 $881,271 - $1.08 Million
-30,057 Reduced 14.94%
171,084 $5.46 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $879,385 - $1.42 Million
-29,167 Reduced 12.66%
201,141 $6.16 Million
Q4 2022

Feb 14, 2023
SELL
$36.73 - $51.6 $464,597 - $652,688
-12,649 Reduced 5.21%
230,308 $9.01 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $536,806 - $948,552
13,491 Added 5.88%
242,957 $11.6 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $519,952 - $1.09 Million
17,413 Added 8.21%
229,466 $8.88 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $480,185 - $734,263
8,937 Added 4.4%
212,053 $12.5 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $518,244 - $754,738
7,619 Added 3.9%
203,116 $16.2 Million
Q3 2021

Nov 12, 2021
BUY
$84.37 - $133.6 $838,469 - $1.33 Million
9,938 Added 5.36%
195,497 $20.1 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $1.05 Million - $2.11 Million
16,429 Added 9.71%
185,559 $23.9 Million
Q1 2021

May 17, 2021
SELL
$71.28 - $120.75 $2.36 Million - $4 Million
-33,166 Reduced 16.39%
169,130 $13.5 Million
Q4 2020

May 17, 2021
BUY
$22.24 - $95.63 $314,206 - $1.35 Million
14,128 Added 7.51%
202,296 $16.5 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $1.29 Million - $5.53 Million
57,797 Added 44.33%
188,168 $15.4 Million
Q3 2020

Nov 16, 2020
BUY
$19.0 - $30.57 $1.31 Million - $2.1 Million
68,697 Added 111.39%
130,371 $3.21 Million
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $237,766 - $446,551
15,581 Added 33.8%
61,674 $1.73 Million
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $613,497 - $1.35 Million
46,093 New
46,093 $829,000

Others Institutions Holding BEAM

# of Institutions
245
Shares Held
95.7M
Call Options Held
666K
Put Options Held
1.99M
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.85B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email